|
From the knowledge of immunity and inflammation to immunotherapy against cancer |
Tsukasa Seya |
|
Role of bone Marrow-Derived CCR1[+] cells in colon cancer invasion and metastasis |
Makoto Mark Taketo |
|
PGE[2]-associated inflammation and gastrointestinal tumorigenesis |
Hiroko Oshima, Masanobu Oshima |
|
The role of innate immune signaling in regulation of tumor-associated myeloid cells |
Hiroaki Shime, Misako Matsumoto, Tsukasa Seya |
|
The role of PIKfyve in toll-like receptor-mediated responses |
Kaoru Hazeki, Kiyomi Nigorikawa, Osamu Hazeki |
|
Emerging roles of an innate immune regulator TAPE in the toll-like receptor and RIG-I-like receptor pathways |
Kuan-Ru Chen, Pin Ling |
|
Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T cell Leukemia/Lymphoma cells |
Yukiko Miyatake, Masanori Kasahara |
|
Innate immune receptor signaling and IRF family of transcription factors |
Hiroaki Ikushima, Hideyuki Yanai, Tadatsugu Taniguchi |
|
Host factors involved in the propagation and pathogenesis of hepatitis C virus |
Toru Okamoto, Yoshiharu Matsuura |
|
Hepatitis C virus (HCV)-induced inflammation |
Hironori Nishitsuji ...[et. al] |
|
Development of immunotherapy for hepatocellular carcinoma |
Eishiro Mizukoshi, Shuichi Kaneko |
|
Development of Glypican-3-targeted cancer immunotherapy |
Toshiaki Yoshikawa ...[et. al] |
|
The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation |
Norimitsu Kadowaki |
|
In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy |
Shin-ichiro Fujii ...[et. al] |
|
Enhancement of efficacy of wilms' tumor gene WT1 product-derived peptide cancer vaccine by co-administration with Immunopotentiating agents |
Hiroko Nakajima ...[et. al] |
|
Regulation of antigen presentation by dendritic cells and its application to cancer immunotherapy |
Hidemitsu Kitamura ...[et. al] |
|
A new mode of cytotoxic T lymphocyte induction secondary to alteration of the peptide/Major histocompatibility complex class I repertoire by antigen processing defects |
Takayuki Kanaseki, Yosuke Shionoya, Noriyuki Sato |
|
Progress in clinical use of CC chemokine receptor 4 antibody for regulatory T cell suppression |
Susumu Suzuki ...[et. al] |
|
Adjuvant immunotherapy for cancer |
Misako Matsumoto, Masahiro Azuma, Tsukasa Seya |
|
Immunological regulation of human cancer stem Cells/Cancer-Initiating cells |
Noriyuki Sato ...[et. al] |
|
Development of personalized combination cancer immunotherapy based on the patients' immune status |
Yutaka Kawakami ...[et. al] |
|
From the knowledge of immunity and inflammation to immunotherapy against cancer |
Tsukasa Seya |
|
Role of bone Marrow-Derived CCR1[+] cells in colon cancer invasion and metastasis |
Makoto Mark Taketo |
|
PGE[2]-associated inflammation and gastrointestinal tumorigenesis |
Hiroko Oshima, Masanobu Oshima |
図書
